BSG and melanoma: Furthermore, the excessive presence of CD147 is linked to decreased overall survival in patients with primary melanomas [27] and the spread of cancer to deeper layers of skin, indicating that CD147 serves as a significant predictive marker for the aggressiveness of melanoma [28].